Literature DB >> 8636448

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects.

M K Sinha1, J P Ohannesian, M L Heiman, A Kriauciunas, T W Stephens, S Magosin, C Marco, J F Caro.   

Abstract

We studied 24-h profiles of circulating leptin levels using a sensitive and specific RIA in lean controls and obese subjects with or without non-insulin-dependent diabetes mellitus (NIDDM) during normal routine activity. Serum leptin levels were significantly higher in obese (41.7 +/- 9.0 ng/ml; n = 11) and obese NIDDM (30.8 +/- 6.7; n = 9) subjects compared with those in lean controls (12.0 +/- 4.4, n = 6). In all the three groups, serum leptin levels were highest between midnight and early morning hours and lowest around noon to midafternoon. The nocturnal rise in leptin levels was significant when data were analyzed by ANOVA (lean: F = 3.17, P < 0.0001, n = 4; obese: F = 2.02, P < 0.005, n = 11; and obese NIDDM: F = 4.9, P < 0.0001, n = 5). The average circadian amplitude between acrophase and nadir was 75.6% in lean, 51.7%, in obese and 60.7% in obese NIDDM groups, respectively. No significant correlations (P > 0.05) were observed between circulating levels of leptin and either insulin or glucose levels in any of the 20 subjects studied for 24-h profiles. The nocturnal rise in leptin observed in the present study resembles those reported for prolactin, thyroid-stimulating hormone, and free fatty acids. We speculate that the nocturnal rise in leptin could have an effect in suppressing appetite during the night while sleeping.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636448      PMCID: PMC507189          DOI: 10.1172/JCI118551

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  Diurnal and ultradian rhythms in human endocrine function: a minireview.

Authors:  E Van Cauter
Journal:  Horm Res       Date:  1990

2.  Decreased basal and stimulated thyrotropin secretion in healthy elderly men.

Authors:  A van Coevorden; E Laurent; C Decoster; M Kerkhofs; P Neve; E van Cauter; J Mockel
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

3.  Effects of "jet lag" on hormonal patterns. IV. Time shifts increase growth hormone release.

Authors:  J Golstein; E Van Cauter; D Désir; P Noël; J P Spire; S Refetoff; G Copinschi
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

4.  Nocturnal decrease in glucose tolerance during constant glucose infusion.

Authors:  E Van Cauter; D Désir; C Decoster; F Féry; E O Balasse
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

5.  Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.

Authors:  C Saloranta; M R Taskinen; E Widen; M Härkönen; A Melander; L Groop
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

6.  Cortisol secretion is inhibited during sleep in normal man.

Authors:  E D Weitzman; J C Zimmerman; C A Czeisler; J Ronda
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

7.  Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.

Authors:  E T Shapiro; H Tillil; K S Polonsky; V S Fang; A H Rubenstein; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

8.  Growth hormone secretion during sleep.

Authors:  Y Takahashi; D M Kipnis; W H Daughaday
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

9.  Control of circadian and episodic variations of adrenal androgens secretion in man.

Authors:  C Lejeune-Lenain; E Van Cauter; D Désir; M Beyloos; J R Franckson
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

10.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

View more
  130 in total

Review 1.  Leptin and exercise: new directions.

Authors:  J L Durstine; R W Thompson; K L Drowatzky; W P Bartoli
Journal:  Br J Sports Med       Date:  2001-02       Impact factor: 13.800

Review 2.  A biomechanical perspective: do foot orthoses work?

Authors:  B Heiderscheit; J Hamill; D Tiberio
Journal:  Br J Sports Med       Date:  2001-02       Impact factor: 13.800

3.  Effect of one morning meal and a bolus of dexamethasone on 24-hour variation of serum leptin levels in humans.

Authors:  B Laferrère; S K Fried; T Osborne; F X Pi-Sunyer
Journal:  Obes Res       Date:  2000-10

Review 4.  Regulation of leptin production.

Authors:  R V Considine
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

5.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; J W Kolaczynski; M Polansky
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 6.  Role of the adipocyte-derived hormone leptin in reproductive control.

Authors:  David Garcia-Galiano; Susan J Allen; Carol F Elias
Journal:  Horm Mol Biol Clin Investig       Date:  2014-09

7.  [Circadian rhythms in endocrinology].

Authors:  B Schultes; H L Fehm
Journal:  Internist (Berl)       Date:  2004-09       Impact factor: 0.743

Review 8.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

Review 9.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

10.  Serum leptin levels and reproductive function during the menstrual cycle.

Authors:  Katherine Ahrens; Sunni L Mumford; Karen C Schliep; Kerri A Kissell; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Am J Obstet Gynecol       Date:  2013-11-08       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.